Data Integrity: US FDA Guidance Seeks To Head Off Bioavailability/Bioequivalence Study Problems

 
• By Sue Sutter
  
Drawing bullseye
A new guidance takes aim at the data integrity problems that have plagued industry in recent years. • Source: Shutterstock
Pink Sheet Podcast

Have you checked out Pink Sheet podcast?

New episodes every Thursday.

SpotifyApple PodcastsWebsite

More from Generics

More from Biosimilars & Generics